Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris

Katharina Boch; Ewan A. Langan; Nina van Beek; Khalaf Kridin; Enno Schmidt; Detlef Zillikens; Ralf J. Ludwig; Christoph M. Hammers; Katja Bieber

doi:10.2340/actadv.v102.4490

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris

Katharina Boch, Ewan A. Langan, Nina van Beek, Khalaf Kridin, Enno Schmidt, Detlef Zillikens, Ralf J. Ludwig, Christoph M. Hammers^*, Katja Bieber

^*Korrespondierende/r Autor/-in für diese Arbeit

Bar-Ilan University

Originalsprache	Englisch
Aufsatznummer	adv00835
Zeitschrift	Acta Dermato-Venereologica
Jahrgang	102
ISSN	0001-5555
DOIs	https://doi.org/10.2340/actadv.v102.4490
Publikationsstatus	Veröffentlicht - 2022

Fördermittel

This work was supported by Deutsche Forschungsgemeinschaft through Research Training Group (GRK 1727/1) “Modulation of Autoimmunity”, the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (EXC 2167), and the Schleswig-Holstein Excellence-Chair Program from the State of Schleswig Holstein. This work was supported by Deutsche Forschungsgemeinschaft through Research Training Group (GRK 1727/1) “Modulation of Autoimmunity”, the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (EXC 2167), and the Schleswig-Holstein Excellence-Chair Program from the State of Schleswig Holstein. The study was approved by the institutional review board (Uni-versity of Lübeck, #12-178) and performed in accordance with the Declaration of Helsinki.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gesundheit und Wohlergehen

Dokumente

10.2340/actadv.v102.4490

Weitere Links

Link to publication in Scopus

SFB 1526, PANTAU: Pathomechanismen Antikörpervermittelter Autoimmunerkrankungen
Sadik, C. (Sprecher*in), Zillikens, D. (Sprecher*in), Scheffold, A. (Projektleiter*in (PI)), Schmidt, E. (Projektleiter*in (PI)), Heine, G. (Projektleiter*in (PI)), Manz, R. (Projektleiter*in (PI)), Köhl, J. (Projektleiter*in (PI)), Ludwig, R. (Projektleiter*in (PI)), Peipp, M. (Projektleiter*in (PI)), Hammers, M. C. (Projektleiter*in (PI)), Verschoor, A. (Projektleiter*in (PI)), Karsten, C. (Projektleiter*in (PI)), Nimmerjahn, F. (Projektleiter*in (PI)), Hutloff, A. (Projektleiter*in (PI)), Ibrahim, S. (Projektleiter*in (PI)), Wettschureck, N. (Projektleiter*in (PI)), Bieber, K. (Projektleiter*in (PI)), Schilf, P. (Projektleiter*in (PI)), Vaeth, M. (Projektleiter*in (PI)), Hirose, M. (Projektleiter*in (PI)), Vaeth, M. (Projektleiter*in (PI)), Baines, J. F. (Projektleiter*in (PI)), Bacher, P. (Projektleiter*in (PI)), Hoffmann, M. (Projektleiter*in (PI)), Busch, H. S. (Projektleiter*in (PI)), Höppner, M. (Projektleiter*in (PI)), Becker, M. (Projektleiter*in (PI)), Holtsche, M. M. (Projektleiter*in (PI)), Fähnrich, A. (Projektleiter*in (PI)), Szymczak, S. (Projektleiter*in (PI)), Murthy, S. (Projektleiter*in (PI)) & Lux, A. (Projektleiter*in (PI))
01.01.22 → …
Projekt: DFG Verbundprojekte › DFG Sonderforschungsbereiche / Transregios (SFB/TR)

Zitieren

@article{5f5f4d5dcc164eb792ef9bc32864922b,

title = "Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris",

author = "Katharina Boch and Langan, \{Ewan A.\} and \{van Beek\}, Nina and Khalaf Kridin and Enno Schmidt and Detlef Zillikens and Ludwig, \{Ralf J.\} and Hammers, \{Christoph M.\} and Katja Bieber",

note = "Funding Information: This work was supported by Deutsche Forschungsgemeinschaft through Research Training Group (GRK 1727/1) “Modulation of Autoimmunity”, the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (EXC 2167), and the Schleswig-Holstein Excellence-Chair Program from the State of Schleswig Holstein. Funding Information: This work was supported by Deutsche Forschungsgemeinschaft through Research Training Group (GRK 1727/1) “Modulation of Autoimmunity”, the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (EXC 2167), and the Schleswig-Holstein Excellence-Chair Program from the State of Schleswig Holstein. The study was approved by the institutional review board (Uni-versity of L{\"u}beck, \#12-178) and performed in accordance with the Declaration of Helsinki.",

year = "2022",

doi = "10.2340/actadv.v102.4490",

language = "English",

volume = "102",

journal = "Acta Dermato-Venereologica",

issn = "0001-5555",

publisher = "Medical Journals Sweden AB",

}

TY - JOUR

T1 - Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris

AU - Boch, Katharina

AU - Langan, Ewan A.

AU - van Beek, Nina

AU - Kridin, Khalaf

AU - Schmidt, Enno

AU - Zillikens, Detlef

AU - Ludwig, Ralf J.

AU - Hammers, Christoph M.

AU - Bieber, Katja

N1 - Funding Information: This work was supported by Deutsche Forschungsgemeinschaft through Research Training Group (GRK 1727/1) “Modulation of Autoimmunity”, the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (EXC 2167), and the Schleswig-Holstein Excellence-Chair Program from the State of Schleswig Holstein. Funding Information: This work was supported by Deutsche Forschungsgemeinschaft through Research Training Group (GRK 1727/1) “Modulation of Autoimmunity”, the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (EXC 2167), and the Schleswig-Holstein Excellence-Chair Program from the State of Schleswig Holstein. The study was approved by the institutional review board (Uni-versity of Lübeck, #12-178) and performed in accordance with the Declaration of Helsinki.

PY - 2022

Y1 - 2022

UR - https://www.scopus.com/pages/publications/85143993164

U2 - 10.2340/actadv.v102.4490

DO - 10.2340/actadv.v102.4490

M3 - Comments/Debates

C2 - 36511332

AN - SCOPUS:85143993164

SN - 0001-5555

VL - 102

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

M1 - adv00835

ER -

Faster IgG4 Depletion Kinetics Observed for Anti-Desmoglein 3 Autoantibodies Following Rituximab Treatment in Patients with Pemphigus Vulgaris

Fördermittel

UN SDGs

Dokumente

Weitere Links

Projekte

SFB 1526, PANTAU: Pathomechanismen Antikörpervermittelter Autoimmunerkrankungen

Zitieren